Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Yidu Tech, Inc. ( (HK:2158) ) is now available.
Yidu Tech Inc. announced that its affiliate Yidu Cloud (Beijing) Technology Co., Ltd. has won a bid to provide clinical trial site management organization technical services for the PIONEER2 project at the First Affiliated Hospital of Guangzhou Medical University, with the contract valued at about RMB4.1 million. The deal strengthens Yidu Tech’s role in China’s clinical research infrastructure, illustrating how its AI-driven capabilities are being adopted by major medical institutions and potentially deepening its integration into the broader healthcare value chain.
More about Yidu Tech, Inc.
Yidu Tech Inc. is a China-focused health technology company that uses artificial intelligence and data-driven tools to support the intelligent upgrading of the healthcare system. Its platforms aim to empower hospitals, pharmaceutical companies, insurers and patients by simulating clinical decision-making, improving precision diagnostics and treatments, and offering system-level intelligence for a more resilient and inclusive healthcare ecosystem.
Average Trading Volume: 7,418,931
Technical Sentiment Signal: Buy
Current Market Cap: HK$6.62B
See more data about 2158 stock on TipRanks’ Stock Analysis page.